Roth Capital says that while Neutral-rated LivePerson’s (LPSN) Q4 2024 results supported $32M in run-rate AEBITDA, Q1 2025 results left revenues in decline and AEBITDA slashed to $0.2M. With roughly $360M in convertible debt maturing in Q4 2026, the firm does not see a credible path to refinance its debts without massive equity dilution. Roth chooses not to downgrade to Sell as it believes a sale of the company could risk material losses to a short position. “We believe shorting the shares is too risky to advocate as we believe LPSN could be worth more in an outright sale, an outcome we are starting to believe is its only viable path to survival,” it adds.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LPSN: